The first US patient has been enrolled in Dextera Surgical’s MicroCutter Assisted Thoracic Surgery Hemostasis (MATCH) registry, a prospective, open-label, multicentre registry enrolling up to 120 patients undergoing lung resections in which surgical stapling is required.
The registry will evaluate the effectiveness of the MicroCutter 5/80 surgical stapler for haemostasis (stopping the flow of blood) and the procedure enabling aspects of the device in lobectomy or segmentectomy lung surgery procedures using a variety of minimally invasive techniques including video-assisted thoracic surgery (VATS) and robotic-assisted surgeries, as well as in open surgery.
US centres including the Mayo Clinic (Rochester, USA) where the first US MATCH patient was enrolled, will be involved in the registry. Additionally, ten patients have already been enrolled internationally at the James Cook University Hospital (Middlesbrough, UK).
Other leading research institutions expected to participate in the MATCH Registry include University of Alabama at Birmingham, USA, the University of Texas MD Anderson Cancer Center, Houston, USA, and the Royal Infirmary in Edinburgh, Scotland, as well as several additional international sites.
“The MATCH registry will provide important clinical data regarding the haemostasis performance of the MicroCutter 5/80 while capturing video evidence of the ability of the device to navigate in tight spaces to enable less-invasive methods for treating patients undergoing lung surgery,” says David Rice, professor at the University of Texas MD Anderson Cancer Center.
